MarketScreener Homepage > News > Companies > Press Releases

News : Companies

05:30p	Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gol Linhas Aereas Inteligentes S.A. - GOL	GL
05:14p	Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strongbridge Biopharma plc - SBBP	GL
05:05p	MANCHESTER UNITED : Disjointed and overrun, Man Utd slumps to loss on EPL return	AQ
04:36p	Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX	GL
04:05p	ASPEN : Investor Presentation	PU
02:46p	NANO X IMAGING : ROSEN, A GLOBALLY RECOGNIZED FIRM, First Files Securities Class Action Lawsuit Against Nano-X Imaging Ltd. - NNOX	PR
02:20p	LINCOLN NATIONAL : Financial Group Statement on the Death of Justice Ruth Bader Ginsburg	PU
01:45p	PETRONOR E&P : Agreement with The Gambia	PU
01:45p	ENTERGY : Hurricane Laura Restoration Update - 9/19/20 @ 11 a.m.	PU
01:30p	ESMO 2020 : Cabometyx® (cabozantinib) in combination with Opdivo® (nivolumab) demonstrates significant survival benefits in patients with advanced renal cell carcinoma in pivotal Phase III CheckMate -9ER trial	PU
01:24p	PETRONOR E&P : Agreement with The Gambia	AQ
01:22p	ACTBLUE : Ginsburg's death draws big surge of donations to Democrats	AQ
01:21p	ACTBLUE : Ginsburg's death draws big surge of donations to Democrats	AQ
01:05p	ASTRAZENECA : TAGRISSO Reduced the Risk of Disease Recurrence in the Brain by 82% in the Adjuvant Treatment of Early-Stage EGFR-Mutated Lung Cancer	BU
12:32p	BRISTOL MYERS SQUIBB : Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Demonstrates Significant Survival Benefits in Patients with Advanced Renal Cell Carcinoma in Pivotal Phase 3 CheckMate -9ER Trial	BU

The best opportunities.
All the markets. Each month. In one click.

Discover

12:31p	ESMO 2020 : Cabometyx® (cabozantinib) in Combination With Opdivo® (nivolumab) Demonstrates Significant Survival Benefits in Patients With Advanced Renal Cell Carcinoma in Pivotal Phase III CheckMate -9ER Trial	BU
12:01p	MEDIA AVAILABILITY : CN Police officers available for media interviews during Rail Safety Week	AQ
12:01p	MEDIA AVAILABILITY : CN Police officers available for media interviews during Rail Safety Week	GL
11:45a	IMMUNOMEDICS : Trodelvyᵀᴹ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer	PU
11:45a	IMMUNOMEDICS : Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvyᵀᴹ in Metastatic Urothelial Cancer	PU
11:15a	INFO EDGE INDIA : Investor Conference	PU
11:14a	NSP Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Insperity Inc.	GL
11:01a	IMMUNOMEDICS : Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer	AQ
11:01a	Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer	GL
10:45a	ROCHE : presents new data from multiple Phase III studies of Tecentriq in triple-negative breast cancer at ESMO Virtual Congress 2020	PU
10:31a	IMMUNOMEDICS : Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer	AQ
10:31a	Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer	GL
10:25a	Novartis Piqray® data show survival benefit for patients with HR+/HER2- advanced breast cancer with a PIK3CA mutation	GL
10:21a	ROCHE : presents new data from multiple Phase III studies of Tecentriq in triple-negative breast cancer at ESMO Virtual Congress 2020	AQ
10:21a	MERCK : KEYTRUDA® (pembrolizumab) Reduced the Risk of Distant Metastasis or Death by 40% Versus Placebo as Adjuvant Treatment in Resected, High-Risk Stage III Melanoma	BU
10:21a	GENENTECH : Presents New Data From Multiple Phase III Studies of Tecentriq in Triple-Negative Breast Cancer at ESMO Virtual Congress 2020	BU
10:20a	Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar® and Mekinist® in advanced melanoma	GL
10:20a	Roche presents new data from multiple Phase III studies of Tecentriq in triple-negative breast cancer at ESMO Virtual Congress 2020	GL
09:16a	COSTA'S CRUISES RETURN TO GENOA : Costa Diadema Sails Today	PR
09:00a	WIIT S P A : myLoc acquisition	PU
08:55a	Announcing Killer Mike as Keynote Speaker at UNCF/Koch Scholars Program Virtual Summit	GL
08:06a	ITERA : Grief As Kyerwa Pays Last Respects to Deceased Children	AQ
08:00a	WALMART : Amazon among donors to QAnon-promoting lawmaker	AQ
07:58a	BASEBALL : Pacific League standings (Sept. 19)	AQ
07:31a	ZAI LAB : Phase 3 NORA data of ZEJULA® (niraparib) demonstrate significant PFS benefit, regardless of biomarker status, with an improved safety profile when given with individualized starting dose regimen in Chinese women with platinum-sensitive recurrent ovarian cancer	AQ
07:31a	Phase 3 NORA data of ZEJULA® (niraparib) demonstrate significant PFS benefit, regardless of biomarker status, with an improved safety profile when given with individualized starting dose regimen in Chinese women with platinum-sensitive recurrent ovarian cancer	GL
06:45a	STANDARD CHARTERED : We've completed our first cross-bank Letter of Credit blockchain transaction between Vietnam and Thailand	PU
06:25a	G20 Trade and Investment Ministers Meeting - Press Release	PU
06:25a	JSE : TEST JSE Regulatory Announcement	PU
05:20a	MARSHAL LION FINANCIAL GROUP CORP : A Marshal Lion mobile app has reached many users' smartphones in record time.	EQ
03:00a	Axion Receives Petition to the Court and Notice of Civil Claim	NE
02:15a	ELLIS MARTIN REPORT : OriginClear's (OTCMKTS:OCLN) Riggs Eckelberry on Investment Potential in Water Systems	AQ
02:15a	ELLIS MARTIN REPORT : OriginClear's (OTCMKTS:OCLN) Riggs Eckelberry on Investment Potential in Water Systems	AW
02:07a	AUB : Entitlement to indemnity under marine transit insurance	AQ
01:50a	ELLIS MARTIN REPORT : Rockridge Resources (VAN:ROCK) Commences 3,000 Metre Diamond Drill Program at its High-Grade Raney Gold Project	AQ
01:50a	ELLIS MARTIN REPORT : Rockridge Resources Commences 3,000 Metre Diamond Drill Program at its High-Grade Raney Gold Project	AW
09/19	ELLIS MARTIN REPORT : Gold Terra (VAN:YGT) (OTCMKTS:YGTFF) to Earn up to a 60% Interest on Adjacent Mining Claims to the Former Con Mine Owned by Newmont	AQ
09/19	ELLIS MARTIN REPORT : Gold Terra (OTCMKTS:YGTFF) to Earn up to a 60% Interest on Adjacent Mining Claims to the Former Con Mine Owned by Newmont	AW
09/18	International open ideas competition announces 3 finalists for iconic landmark in Silicon Valley	PR
09/18	COVID-19 RECOVERY ANALYSIS : HVDC Converter Stations Market \| Increase in Global Power Demand to Boost Market Growth \| Technavio	BU
09/18	AIRBUS : HTM-Helicopters to become the first operator to use the new H145 for Offshore Wind operations	PU
09/18	AIRBUS : Helicopters and HTM-Helicopters have signed a contract for the purchase of two additional H145 helicopters. ...	PU
09/18	ADVANTECH : Launches UNO-137 Integrated IoT Edge for Industry 4.0 Applications	PU
09/18	HORIZONTAL CAROUSEL MARKET : COVID-19 Business Continuity Plan \| Evolving Opportunities with Bastian Solutions LLC and Conveyors & Drives Inc. \| Technavio	BU
09/18	MOHAWK INDUSTRIES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL : Kahn Swick & Foti, LLC Investigates the Officers and Directors of Mohawk Industries, Inc. - MHK	BU

1 2 3 4 5 6 7 8 9 10 Next

MOST READ NEWS

1	TENCENT HOLDINGS LIMITED : Trump to shut off TikTok, WeChat to new U.S. users on Sunday
2	INTEL CORPORATION : KEYWORDS: Moore's Law Is Dead. Long Live Huang's Law. -- WSJ
3	TESLA, INC. : TESLA : Judge narrows Tesla lawsuit against former employee, dismisses defamation counterclaim
4	GENERAL MOTORS COMPANY : The Incredible Shrinking GM -- WSJ -2-
5	IPSEN : ESMO 2020: Cabometyx® (cabozantinib) in Combination With Opdivo® (nivolumab) Demonstrates Significant ..